Verrica Pharmaceuticals Inc. - stock earnings
VRCA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -25.1 million USD | 2.0 million USD |
| 2023Q3 | -24.8 million USD | 2.9 million USD |
| 2023Q2 | -11.0 million USD | 182000 USD |
| 2023Q1 | -6.1 million USD | 37000 USD |
| 2022Q4 | -5.7 million USD | 68000 USD |
| 2022Q3 | -1.3 million USD | 8.3 million USD |
| 2022Q2 | -11.2 million USD | 214000 USD |
| 2022Q1 | -9.5 million USD | 431000 USD |
| 2021Q4 | -9.5 million USD | -12.0 million USD |
| 2021Q3 | -12.8 million USD | ? USD |
| 2021Q2 | -11.8 million USD | ? USD |
| 2021Q1 | -936000 USD | 12.0 million USD |
| 2020Q4 | -13.0 million USD | ? USD |
| 2020Q3 | -10.5 million USD | ? USD |
| 2020Q2 | -9.4 million USD | ? USD |
| 2020Q1 | -9.8 million USD | ? USD |
| 2019Q4 | -7.6 million USD | ? USD |
| 2019Q3 | -6.1 million USD | ? USD |
| 2019Q2 | -7.0 million USD | ? USD |
| 2019Q1 | -7.5 million USD | ? USD |
| 2018Q4 | -7.6 million USD | ? USD |
| 2018Q3 | -6.7 million USD | ? USD |
| 2018Q2 | -6.0 million USD | ? USD |
| 2018Q1 | -1.9 million USD | ? USD |
| 2017Q4 | -1.4 million USD | ? USD |
| 2017Q3 | -1.4 million USD | ? USD |
| 2017Q2 | -1.1 million USD | ? USD |
| 2017Q1 | -570000 USD | ? USD |
| 2016Q4 | -1.9 million USD | ? USD |
VRCA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -67.0 million USD | 5.1 million USD |
| 2022 | -27.7 million USD | 9.0 million USD |
| 2021 | -38.9 million USD | 12.0 million USD |
| 2020 | -45.5 million USD | 12.0 million USD |
| 2019 | -28.0 million USD | ? USD |
| 2018 | -20.6 million USD | ? USD |
| 2017 | -4.5 million USD | ? USD |
| 2016 | -1.9 million USD | ? USD |
VRCA
Price: $6.76
52 week price:
Earnings Per Share: -1.48 USD
P/E Ratio: -5.10
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 337100
Market Capitalization: 299.1 million